Agent Astro is a Regulatory Intelligence Platform for MedTech organizations. It helps teams connect evidence, institutional knowledge, and regulatory context to support better decisions across the product lifecycle.

Agent Astro is built for MedTech organizations, with a primary focus on regulatory leaders and specialists responsible for making and supporting critical decisions.

It also supports executives, consultants, and clinical teams who depend on regulatory intelligence throughout the product lifecycle.

General-purpose AI tools are optimized for breadth.

Agent Astro is optimized for precision.

By combining specialized regulatory intelligence, traceable evidence, prior decisions, and MedTech-specific context, Agent Astro helps teams make decisions with greater confidence while maintaining visibility into the evidence supporting those decisions.

Better decisions require more than information. They require the right evidence, the right context, and confidence that important factors have not been overlooked.

Agent Astro helps teams connect regulatory precedent, standards, guidance documents, company knowledge, and supporting evidence so decisions can be made with greater precision, confidence, and defensibility.

Different teams face different questions.

These decisions may involve regulatory pathways, evidence generation, standards, clinical strategy, commercialization, reimbursement, product changes, and lifecycle planning.

Organizations build valuable knowledge through projects, submissions, regulatory interactions, internal analyses, and past decisions. Agent Astro helps teams preserve and reuse that knowledge so future work does not start from zero.

No. Agent Astro is designed to complement existing systems such as document repositories, eQMS platforms, PLM systems, requirements tools, and submission archives. Agent Astro acts as an intelligence layer that helps teams connect and interpret information across those systems.

Yes.

Agent Astro can analyze internal documents, prior submissions, technical files, quality records, and team expertise alongside regulatory precedent, standards, guidance documents, and supporting evidence.

This allows organizations to build on what they already know, preserve institutional knowledge, and make decisions using both internal expertise and external intelligence.

Agent Astro supports regulatory activities across the global MedTech landscape.

Organizations use Agent Astro to support FDA 510(k), De Novo, and PMA programs, as well as regulatory activities across major global markets and regulatory frameworks.

The platform also supports quality, clinical, reimbursement, commercialization, and product lifecycle activities by connecting evidence, prior decisions, and regulatory intelligence in a single platform.

Whether evaluating a new opportunity, planning a submission strategy, assessing evidence requirements, preparing for market expansion, or managing product changes, Agent Astro helps organizations make better decisions with greater precision, confidence, and consistency.

Agent Astro is built with security in mind. The platform uses secure infrastructure and encryption to help protect proprietary documents, regulatory information, and company knowledge.

Most organizations begin by using Agent Astro to answer specific regulatory or product questions.

Over time, teams expand its use to support regulatory strategy, evidence planning, quality initiatives, clinical activities, commercialization decisions, and knowledge continuity.

As the platform accumulates evidence, analyses, and historical context, it becomes a growing source of secure intelligence that supports decisions across the organization.